Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration
Top Cited Papers
- 5 December 2006
- journal article
- review article
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 4 (14), 413-437
- https://doi.org/10.1098/rsif.2006.0179
Abstract
Advanced therapies combating acute and chronic skin wounds are likely to be brought about using our knowledge of regenerative medicine coupled with appropriately tissue-engineered skin substitutes. At the present time, there are no models of an artificial skin that completely replicate normal uninjured skin. Natural biopolymers such as collagen and fibronectin have been investigated as potential sources of biomaterial to which cells can attach. The first generation of degradable polymers used in tissue engineering were adapted from other surgical uses and have drawbacks in terms of mechanical and degradation properties. This has led to the development of synthetic degradable gels primarily as a way to deliver cells and/or molecules in situ, the so-called smart matrix technology. Tissue or organ repair is usually accompanied by fibrotic reactions that result in the production of a scar. Certain mammalian tissues, however, have a capacity for complete regeneration without scarring; good examples include embryonic or foetal skin and the ear of the MRL/MpJ mouse. Investigations of these model systems reveal that in order to achieve such complete regeneration, the inflammatory response is altered such that the extent of fibrosis and scarring is diminished. From studies on the limited examples of mammalian regeneration, it may also be possible to exploit such models to further clarify the regenerative process. The challenge is to identify the factors and cytokines expressed during regeneration and incorporate them to create a smart matrix for use in a skin equivalent. Recent advances in the use of DNA microarray and proteomic technology are likely to aid the identification of such molecules. This, coupled with recent advances in non-viral gene delivery and stem cell technologies, may also contribute to novel approaches that would generate a skin replacement whose materials technology was based not only upon intelligent design, but also upon the molecules involved in the process of regeneration.Keywords
This publication has 212 references indexed in Scilit:
- Limb regeneration in higher vertebrates: Developing a roadmapThe Anatomical Record Part B: The New Anatomist, 2005
- Isolation of wound healing/regeneration genes using restrictive fragment differential display-PCR in MRL/MPJ and C57BL/6 miceBiochemical and Biophysical Research Communications, 2005
- Diverse and potent activities of HGF/SF in skin wound repairThe Journal of Pathology, 2004
- Retinoic acid, a regeneration‐inducing moleculeDevelopmental Dynamics, 2003
- Morphogenesis and Renewal of Hair Follicles from Adult Multipotent Stem CellsCell, 2001
- Cloning of mouse FGF10 and up-regulation of its gene expression during wound healing.Gene, 1997
- Involvement of Androgen-Induced Growth Factor (FGF-8) Gene in Mouse Embryogenesis and MorphogenesisBiochemical and Biophysical Research Communications, 1994
- Pigmentation and Inhibition of Wound Contraction by Cultured Skin Substitutes with Adult Melanocytes After Transplantation to Athymic MiceJournal of Investigative Dermatology, 1993
- PDGF AA homodimers are potent chemoattractants for fibroblasts and neutrophils, and for monocytes activated by lymphocytes or cytokinesBiochemical and Biophysical Research Communications, 1992
- Epidermal downgrowths in regenerating rabbit ear holesJournal of Morphology, 1975